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ABSTRACT  
The development of safe technologies to genetically modify neurons is of high interest in regenerative 
neurology, for both translational and basic science applications. Such approaches have conventionally been 
heavily reliant on viral transduction methods which have safety and production limitations. Magnetofection 
(magnet-assisted gene transfer using iron oxide nanoparticles as vectors) has emerged as a highly promising 
non-viral alternative for safe and reproducible genetic modification of neurons. Despite the high promise of 
this technology, there is an important gap in our knowledge of the safety of this approach, namely, whether it 
alters neuronal function in adverse ways such as by altering neuronal excitability and signalling. We have 
investigated the effects of magnetofection in primary cortical neurons by examining neuronal excitability using 
the whole cell patch clamp technique. We found no evidence that magnetofection alters the voltage-dependent 
sodium and potassium ionic currents that underpin excitability. Our study provides important new data 
supporting the concept that magnetofection is a safe technology for bioengineering of neuronal cell 
populations. 
 
KEYWORDS  
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1.  Introduction 
The endogenous repair capacity of the central 
nervous system (CNS) following injury or disease is 
limited; the low capacity of neurons to regenerate is a 
major contributor to this phenomenon [1]. 
Accordingly, extensive basic scientific research has 
been directed towards gaining an enhanced 
understanding of neuronal biology, including the 
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 3 
roles of key genes and proteins that can improve 
neuronal survival and function, in order to inform 
the development of novel therapeutic interventions 
[2]. A major technical issue to consider in this context, 
is the ability to safely and successfully deliver genetic 
material to target neuronal populations. Post-mitotic 
neurons are challenging in this regard, being both 
hard to transfect and showing high sensitivity to 
alterations in their microenvironment, necessitating 
minimal cell manipulation during the genetic 
modification procedures [3]. To this end, both viral 
and non-viral approaches have been used for 
targeted neuronal gene delivery [4]. The key factors 
that determine the suitability of a methodology for 
genetic engineering include (i) transfection efficiency 
achieved, (ii) reproducibility for a given cell type, (iii) 
cost, (iv) technical complexity, (v) production 
scalability and (vi) cytotoxicity. In this regard, 
non-viral gene delivery systems such as 
electroporation, lipofection, and nucleofection can be 
associated with membrane damage and high cell loss, 
considerable expense and low transfection [4,5]. Viral 
methods such as adenoviruses, lentiviruses and 
herpes simplex virus can achieve high transfection 
levels but can be associated with insertional 
mutagenesis, contaminant related toxicity, and 
expensive and time consuming production 
procedures [5]. 
 A promising non-viral alternative for neuronal gene 
transfer that has emerged in recent years, involves 
the use of iron oxide magnetic nanoparticles (MNPs) 
with chemically adaptable surfaces, allowing bound 
genetic material to be targeted to cells by application 
of static or oscillating magnetic fields 
(Magnetofection) [6]. This approach is rapid, 
technically simple, safe and low cost. It has been 
used extensively for genetic modification of both 
neuronal cell lines and primary neurons, including 
for delivery of physiologically relevant biomolecules. 
For example, reporter genes (such as GFP) have been 
delivered in transfection studies of neurons derived 
from stem cells [7], as well as in embryonic primary 
motor neurons [8], in order to test the suitability of 
this method at different developmental stages. The 
approach has also been used to study the localization 
and axonal transport of the spinal muscular atrophy 
protein (SMN) in motor neurons [8]. Other studies 
have successfully utilised magnetofection to 
overexpress the gene encoding scaffolding protein 
RanBP9 in primary cortical neurons, with a resultant 
reduction in dendritic spine density [9]. Further, this 
technique has been applied in gene knockdown 
studies to decrease the synaptic GTPase activating 
protein (SynGAP) expression via the sustained 
expression of short hairpin RNA (shRNA) in neurons 
for up to six days [10]. 
This bioengineering strategy has now been 
successfully used for a wide range of neuronal 
transfection applications by laboratories worldwide. 
Despite its high utility, it should be noted that 
investigations into the potential adverse effects of 
this technology on neuron biology rely almost 
exclusively on relatively simple histological readouts 
such as cell adherence, phenotypic evaluation, 
live/dead staining, viable cell counts using flow 
cytometry, mitochondrial toxicity assays and lactate 
dehydrogenase (LDH) activity [11]. However, a 
crucial knowledge gap currently exists in relation to 
magnetofection technology for neuronal applications, 
namely, whether this bioengineering approach alters 
neuronal excitability. This is a critical issue to address 
as nanoparticles such as carbon black (CB), hematite 
(Fe2O3), and titanium dioxide (TiO2) were found to 
alter spiking patterns in primary murine cortical 
neurons cultured on microelectrode array 
neuro-chips in a concentration dependent manner 
[12]. The acute electrophysiological effects were 
studied after particle addition to cells. 
Multi-parametric assessment of changes in electrical 
activity showed a decrease in the number of action 
potentials, with altered patterns in terms of spike 
and burst rate. Silver nanoparticles were also found 
to reduce sodium current size and action potential 
amplitude in a concentration-dependent manner in 
whole-cell recordings from hippocampal CA1 
neurons in brain slices [13]. A 30% decrease in 
amplitude and -6mV shift in the activation curve of 
sodium current was observed.  
To address this important issue we have conducted 
for the first time an electrophysiological analysis 
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 4 
(using single cell patch clamp recordings) into the 
effect of magnetofection on the voltage-dependent 
ion channels that underpin excitability in primary 
cortical neurons.  
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2. Materials and methods 
 
The care and use of animals was in accordance with 
the Animals (Scientific Procedures) Act of 1986 
(United Kingdom) with approval by the local ethics 
committee. 
 
2.1 Equipment and reagents  
Cell culture-grade plastics, Hanks Balanced salt 
solution (HBSS; calcium and magnesium free), B27 
serum-free supplement [14], glutaMAX-I, penicillin 
and streptomycin (P/S) and TrypLE (synthetic 
trypsin, with phenol) were obtained from Fisher 
(Loughborough, UK). Chemicals for 
electrophysiology, phosphate buffer saline (PBS) 
and N-2-hydroxyethylpiperazine-N-2-ethane 
sulfonic acid (HEPES) were from Sigma-Aldrich 
(Poole, Dorset, UK). Neurobasal, Dulbecco's 
Modified Eagle's medium (DMEM) and F12 media 
were from Invitrogen (Paisley, Scotland, UK). 
Deoxyribonuclease I (DNase I) was from Roche 
(Welwyn, UK). Antibodies: rabbit anti-glial 
fibrillary acidic protein (GFAP; Z0334; Dako 
Cytomation, Ely, UK), rabbit anti-β-tubulin (Tuj-1; 
MRB-435P; Covance, Princeton, USA). Cy3- and 
fluorescein isothiocyanate (FITC)-conjugated 
secondary antibodies were from Jackson 
Immunoresearch Laboratories Ltd (West grove, PA, 
USA). Vectashield mounting medium with 4, 
6-diamidino-2-phenylindole (DAPI, nuclear marker) 
was from Vector Laboratories (Peterborough, UK). 
Fetal bovine serum (FBS) and normal donkey serum 
were from Dutscher Scientific (UK) and Stratech 
Scientific (UK) respectively. The magnefect-nano 
system, comprising an array of NdFeB magnets 
(grade N42; field strength of 421 ± 20 mT) matching 
the wells of culture plates, was from nanoTherics 
Ltd (Stoke-on-Trent, UK [15]). This array oscillates 
horizontally beneath the culture plate, with 
programmable frequency and oscillation. 
Neuromag MNPs were from Oz Biosciences 
(Marseilles, France). pMAXGFP plasmid [size 3.5 kb; 
encodes green fluorescent protein (GFP)] was from 
Amaxa Biosciences (Cologne, Germany). 
Tetrodotoxin (TTX) was from Tocris (UK), 
borosilicate glass for patch electrodes from Harvard 
Instruments, blue excitation LED from Cairn 
Instruments, Optimos camera from Q Imaging, 
patch clamp amplifier from HEKA and the Signal 
software and computer interface (Power 1401) was 
from CED. 
 
2.2 Culture of primary cortical neurons  
Neuronal cells were derived from embryonic day 18 
(E18) CD1 mouse cortex. Pregnant mice were killed 
by cervical dislocation and the uterus was exposed 
by cutting the abdominal cavity using scissors 
sterilized with 70% ethanol. The uterus was placed in 
a petri dish containing ice-cold dissection medium 
(97.5% HBSS, 15 mM HEPES, 50 U mL-1 penicillin, 50 
µg mL-1 streptomycin). The embryos were 
decapitated very quickly into ice-cold HBSS. Cortical 
tissue was extracted and minced using a sterile 
scalpel blade and incubated with 250 µl of TrypLE 
and incubated for 20 min with shaking at 37°C. The 
digestion was stopped by adding 1 ml of FBS and 
cells were dissociated mechanically for 1-2 min and 
then strained (70 µm followed by 40 µm). Cells were 
seeded at 1x105 cells ml-1 in 24 well plates with 400 
µL growth medium (96% Neurobasal medium, 2% 
B-27, 2 mM glutaMAX-I, 50 U mL-1 penicillin, 50 µg 
mL-1 streptomycin) placed in standard humidified 
incubator (37°C, 95% air/5% CO2), and the cells 
allowed to adhere to the coverslip (<1 h). Then the 
medium was replaced with 600 µL fresh growth 
medium, with a 50% medium change every 2-3 days.  
 
2.3 Transfection (magnetofection) 
At 7 days in vitro (DIV), medium was replaced with 
225 µL antibiotic-free growth medium. 
MNP-plasmid complexes were formed by diluting 
(per well) 178 ng pMAXGFP plasmid in 75 µL 1:1 
DMEM: F12 and adding 0.62 µL Neuromag (20 min, 
room temperature). This mixture was added to the 
cells dropwise with gentle swirling of the plate. 75 
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µL DMEM: F12 medium free of complex were added 
to the controls. Plates were then incubated for 30 min 
on the magnefect-nano array system [24 magnets, 
matching the culture plate; frequency (F) = 4 Hz; 
amplitude = 200 nm], then incubated for 24-72 h in 
the absence of the magnetic field [7]. 
 
2.4 Viability (live/dead staining) 
Viability was assessed at 48 h post-magnetofection. 
Cultures were washed gently with PBS, then exposed 
to 4 mM calcein-AM (fluorescent green; indicates live 
cells) and 2 mM ethidium homodimer-1 (fluorescent 
red; indicates dead cells) for 5 min (37°C), washed 
twice with PBS, then imaged immediately. 
Magnetofection-induced toxicity was assessed by 
determining the percentage of viable (calcein positive) 
cells. 
 
2.5 Immunocytochemistry  
Samples were fixed 48 h post-magnetofection (4% 
paraformaldehyde in PBS; 20 min; room temperature) 
before incubation with blocking solution (5% normal 
donkey serum, 0.3% Triton-X in PBS; 30 min), then 
primary antibodies in blocking solution (Tuj1 1:1000; 
anti-GFAP 1:500; 4°C; overnight). Samples were then 
washed three times with PBS, blocked (30 min) and 
incubated with secondary antibodies in blocking 
solution (1:200). Samples were washed three times in 
PBS, then mounted with the nuclear stain DAPI. 
 
2.6 Whole-cell electrophysiological recording 
Whole-cell recordings were made at room 
temperature, using patch pipette electrodes pulled 
with shanks coated with wax to reduce pipette 
capacitance. Neurons cultured on circular coverslips 
were secured, using a small drop of Sylgard, in the 
center of the lid of a 35 mm cell culture dish that 
acted as a chamber. The chamber was filled with 
Neurobasal medium and placed on the stage of an 
Olympus BX51 microscope fitted with an x40 
water-immersion objective (Olympus, NA = 0.8). 
Neurons were identified as GFP positive / negative 
by the presence / absence of GFP fluorescence under 
appropriate epi-fluorescence illumination. Images 
were taken with a Watec 902B camera or Optimos 
camera mounted on the microscope. Voltage-clamp 
protocols were run using Signal software with a 
Power 1401 interface, a patch clamp amplifier (EPC7) 
and a standard laboratory computer. The patch 
pipette filling solution contained (mM): KCl 140, 
Na2ATP 2.5, MgCl2 3.5, EGTA 1, and HEPES 10, 
buffered to pH 7.4 with KOH. The large end of the 
pipette was gently fire polished before filling and 
attachment to the head stage. Pipettes had a 
resistance of 4 MΩ when filled. TTX was prepared as 
a 1 mM stock solution in citrate buffer, frozen in 
aliquots, and dissolved in Neurobasal medium on 
the day of use. It was applied to the neuron from a 
second pipette positioned about 10 µm from the cell 
body and ejected using a picopump (PV820, WPI) 
either manually or via a trigger pulse.  
 
2.7 Fluorescence microscopy and image analysis 
Fluorescence micrographs were taken using an Axio 
Scope A1 (equipped with an Axio Cam ICc1 digital 
camera and AxioVision software, release 4.7.1; Carl 
Zeiss Micro Imaging GmbH, Goettingen, Germany), 
then merged using Photoshop (Adobe, USA). To 
evaluate transfection levels, each DAPI-positive 
nucleus was identified as neuronal (Tuj1+), astrocytic 
(GFAP+), or undetermined (Tuj1-/GFAP-), and scored 
as ‘transfected’ if GFP+. Pyknotic nuclei (indicative of 
necrotic or apoptotic cells) were identified by 
chromosomal condensation, and reported as a 
percentage of all (healthy plus pyknotic) nuclei. 
 
2.8 Data analysis  
For the toxicity assays (live/dead and percentage 
pyknotic nuclei), three sets of micrographs (two from 
the edges and one from the centre of each coverslip; 
each set comprised of counterpart red, green, blue 
and phase contrast images) were captured and 
merged. Values are presented as mean ± standard 
error of the mean. For culture data, n indicates the 
number of cultures (each obtained from different 
pregnant females); for electrophysiological data, n 
indicates the number of cells recorded (derived from 
eight separate litters). Data were analyzed by 
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 7 
two-tailed t-tests (p<0.05 considered significant) 
using either Prism (version 6.0; GraphPad, USA) or 
Origin 2016 (Origin Labs). Electrophysiological 
recordings were analysed using Signal and Origin 
software. Leak subtraction and capacitive transient 
reduction was performed where indicated by the 
addition of currents recorded in response to positive 
(depolarizing) voltage clamp steps to currents 
recorded in response to small (10-40 mV) negative 
voltage clamp steps, scaled and averaged if 
necessary.  
 
3. Results 
 
3.1 Culture characterization 
The proportion of neurons (Tuj1+) and astrocytes 
(GFAP+) was consistent across cultures (25.6 ± 3.2% 
Tuj1+, 58.0 ± 4.5 % GFAP+; n = 3) with 16.3 ± 7.7% of 
nuclei being undetermined (Tuj1-/GFAP-). Neurons 
showed well-defined spherical somata with long 
processes that formed a complex network with 
adjacent neurons. Astrocytes were morphologically 
distinguished as (flat, membranous, unbranched or 
star-shaped; Figure 1).  
 
3.2 Transfection (magnetofection) efficiency  
After magnetofection, 3.2 ± 1.2% of viable cells were 
transfected neurons (GFP+/Tuj1+), and a further 6.3 ± 
3.3% expressed GFP but not Tuj1. These latter cells 
exhibited astrocytic morphologies (Figure 1a and d). 
Statistical analysis demonstrated no significant 
differences between these values. 
 
3.3 Safety assessments of particle toxicity in cortical 
neuronal culture  
No differences were noted between neurons in 
magnetofected and control cultures with respect to 
morphology, percentage of live cells (59.3 ± 9.2%, 53.0 
± 2.0% respectively), number of neurons per 
micrograph (36.3 ± 16.5, 35.6 ± 10.7), or percentage of 
pyknotic nuclei (38.6 ± 3.0%, 35.3 ± 7.8%; Figure 1). 
 
3.4 Electrophysiological characterization  
Neurons for whole cell recording were identified 
under normal light conditions by a bulb-shaped 
soma with long processes often forming a complex 
network, and under blue light (excitation wavelength 
495 nm), by the fluorescence associated with GFP 
protein expression (Figure 2). 
In voltage-clamp experiments, depolarising 
voltage-clamp steps produced biphasic currents 
comprising an early inward current, reaching a peak 
at around 2 ms after the step, followed by a late 
outward current that activated over 5-10 ms (Figure 2 
a and b). The early inward current was found to be 
rapidly blocked by TTX (25 µM) suggesting that it 
was a voltage-dependent Na+ current (Figure 2d). 
The late outward current, which was maintained for 
the duration of the voltage step, was likely to be 
carried by K+ since its reversal potential was negative 
to -60 mV, based on outward tail current polarity at 
-60 mV (Figure 2a). Currents carried by K+ would be 
expected have a reversal potential of -83 mV (the 
calculated K+ equilibrium potential under our 
recording conditions). From a holding potential of 
-60 mV or -70 mV, the Na+ and K+ currents were first 
seen, in response to depolarising steps, at around -40 
mV. The Na+ current activated rapidly (1-3 ms) and 
was maximal at about -20 mV (Figure 2c). A 
comparison between GFP+ and GFP- neurons 
revealed no differences between current amplitudes 
or membrane potential (Student’s t test; Table 1).  
In current clamp, most neurons exhibited a small 
spike following a step depolarising current injection 
(Figure 3a and b). The spikes were 15-30 mV in 
amplitude and did not reach or exceed 0 mV. We also 
noticed in a few cells spontaneous depolarisations 
that increased in amplitude with hyperpolarisation 
(Figure 3a and b).These presumably reflect excitatory 
synaptic activity.  
 
4. Discussion 
 
To our knowledge, this is the first study investigating 
the electrophysiological properties of magnetofected 
primary neurons. We find no evidence for any 
functional influence of magnetofection in these 
10µm 
10µm 
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 8 
relatively immature cortical neurons, based on our 
experiments demonstrating similar amplitudes and 
kinetics of the voltage-dependent Na+ and K+ 
currents. These findings are corroborated by our 
histological observations that did not reveal adverse 
effects of the genetic modification protocols on key 
parameters of cell health. Our use of primary 
neurons has the advantage of eliminating possible 
confounding issues associated with cell lines such as 
their relative homogeneity and clonal nature and 
resistance to nano-toxicity along with genetic drift 
[16-18], enabling a more physiologically relevant 
study to be undertaken.  
 
Our observation that magnetofection did not affect 
the Na+ and K+ channels in cortical neurons is clearly 
an encouraging result in terms of its potential use in 
clinical applications employing cell or tissue 
transplants. It also provides an encouraging platform 
for basic science applications, where the effects of 
transgenes on neuronal function could be 
investigated in the absence of confounding issues, 
such as the decreased cell viability associated with 
some transfection techniques. Clearly, normal ion 
channel function is a prerequisite for normal 
neuronal function in any environment, including 
transplantation into a host. Even in the absence of 
functional synaptic contacts, a transplanted neuron’s 
membrane potential, and ability to spike (all 
functions of ion channels), would be important for 
the health of the neuron and its ability to secrete 
chemicals or neurotransmitters. Our observation of 
apparently spontaneous excitatory synaptic 
potentials is significant since it implies that synaptic 
contacts are functional in these neurons. These 
factors are suggestive of a healthy and maturing cell 
culture amenable to gene manipulation by 
magnetofection. Future studies should assess more 
completely the signalling and synaptic properties of 
such bioengineered neurons. This would require 
both single neuron recordings and recordings of 
neuronal populations in order to build up a picture 
of function and signalling at the single cell and 
multi-cell levels. Given that ion channel dysfunction 
or channelopathy can lead to epileptic seizures and a 
myriad of other problems [19], such information is 
vital before any type of clinical intervention using 
magnetofected neurons or glia can be successfully 
undertaken.  
 
However, cellular uptake of metal or carbon-based 
nanoparticles has been associated with changes in 
spiking frequency and bursting patterns, based on 
neurochip extracellular recordings [12], and with 
alterations in Na+ current amplitude and activation 
range in whole-cell patch recordings [13]. These 
effects are clearly concentration-dependent and are 
subtle at low concentrations of nanoparticles, 
including iron oxide core MNPs [12]. It is possible 
that the conductive properties of the nanoparticle 
themselves may have an influence on cell excitability 
when using conductive materials such as carbon 
black or silver; future research will need to 
investigate this issue in further detail for the 
identification of safe nanomaterials. Comparison 
between studies in terms of metal or particle 
concentration is difficult in as much as uptake into 
the cells is highly dependent on particle size and cell 
type. The MNPs employed here, at ~160 nm diameter 
[20], and with an additional chemical envelope for 
plasmid attachment, are relatively large, but these 
and similar particles have a well-documented safety 
profile across a range of neural cell types [7, 15-18, 
20]. Further investigation should be directed towards 
more mature cells and to track changes 
post-transfection over longer time periods.  
 
Transfection-based bioengineering strategies for 
neural repair will require both efficient and safe 
protocols. Our electrophysiological analysis of 
magnetofected cells was restricted to neurons clearly 
identified as expressing the reporter protein, hence 
the transfection levels obtained do not impact on the 
findings of our study. The overall culture transfection 
efficiency reported here (ca. 10%) is lower than that 
reported for various neuronal types including 
primary cortical neuronal cultures (up to 46%, using 
non-viral approaches combined with high DNA 
concentrations [8]). It should also be noted that the 
protocol employed here was safe over the time 
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course of our experiments in terms of cell survival 
and an apparent absence of pathological changes. 
Multiple factors can be predicted to influence 
transfection efficiency, including: developmental 
stage, conditions of cell culture (e.g. type of media 
used, physicochemical structure of vectors, and 
vector:DNA ratio) [8-10, 21]. These factors are likely 
to account for the differences in observations 
between studies. 
 
It is well established that astrocytes show high levels 
of endocytotic activity in line with their homeostatic 
functions in the nervous system, resulting in 
documented ‘competitive uptake dynamics’ for 
nanoparticle uptake which in co-cultures would limit 
neuronal transfection [15, 16, 22]. Because of this, we 
chose cell culture conditions that would limit 
astrocyte numbers and proliferation. First, by 
deriving cultures from embryonic tissue, astrocyte 
numbers can be kept low, as it is estimated that >90% 
of cells at this developmental time point are neurons 
[23]. Second, the use of serum free medium can (i) 
enhance the purity of neuronal cultures by reducing 
astrocyte proliferation and (ii) provide greater 
definition of experimental conditions by removing 
confounding variation in serum composition [24-26] 
and eliminating the need to use chemical inhibitors 
of astrocytes such as arabinosylcytosine C (AraC) [27, 
28]. Nevertheless, in our hands it proved difficult to 
eliminate the issue of astrocyte contamination 
completely; approximately 35% of the astrocyte 
population can re-enter the cell cycle after serum 
deprivation, likely accounting for the high 
proportions of astrocytes in these cultures [23].  
 
In summary, we provide the first complementary 
electrophysiological and histological analyses 
supporting the concept that iron oxide nanoparticles 
and applied magnetic fields can be safely deployed 
for genetic modification of primary neurons for basic 
research and translational applications.  
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Figure 1. Magnetofection is safe for transfecting primary cortical neuronal cultures. Fluorescence micrographs of  
cortical cultures after 7 days in vitro. (a) Neurons (Tuj1+) display small rounded soma with long processes, astrocytes  
(GFAP+) are flat, membranous and unbranched. (b) Neurons after magnetofection co-express Tuj1 and GFP. The inset shows  
a GFP+ astrocyte (orange arrow) and a Tuj1+/GFP+ neuron (white arrow). (c) Cell viability assay showing viable cells in culture  
(green) and dead cells (orange). (d) Pyknotic nuclei show condensed chromatin (white arrow, inset) in cortical co-culture. The inset  
shows the same arrowed neuron showing the condensed chromatin more clearly.  
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Figure 2. Graphs depicting the safety of magnetofection technique. No alterations are seen in (a) cell viability.  
(b) neuronal number. (c) Percentage of pyknotic nuclei (n = 3). 
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Figure 3. Representative ionic currents seen in response to 
voltage steps from a holding potential of -60 mV from both 
magnetofected (GFP+) and non-magnetofected (GFP-) 
neurons. (a) Voltage steps (top) and corresponding ionic currents 
are shown for GFP+ and GFP- neurons as indicated (bottom two 
rows). (b) Leak-subtracted records shown on a faster time scale 
to reveal early inward (Na+) currents followed by late outward 
(K+) currents. Holding currents have been subtracted. Same cells 
as (a). In (a) and (b) the horizontal (time) and vertical scales are 
shown at the bottom and on the left respectively. (c) I-V plots of 
early inward and late outward currents from GFP+ (top) and GFP- 
neurons (bottom). The late currents (squares) were measured 
from the records shown in (a) at the 40ms time point, the early 
currents (circles) were measured as peak inward currents from 
the records in (b). (d) The inward (Na+) current seen in response 
to a 40 mV depolarising voltage-clamp step from a holding 
potential of -70 mV (left) is blocked by TTX (25 µM, right). The 
voltage steps are shown above the current records. (e) 
Micrographs of magnetofected neurons (GFP+) used for 
whole-cell recording taken under normal transmitted light 
conditions (left) and a combination of low transmitted light and 
fluorescence excitation (right), also showing the recording and 
drug-application pipettes. Scale bars = 10 µm.  
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Figure 4. Representative current clamp recordings from 
magnetofected (GFP+) and non-magnetofected (GFP-) 
neurons showing spike-like activity. (a) Current steps (top) and 
corresponding voltage responses (middle) from a GFP+ neuron. 
The arrows indicate spike-like voltage transients (blue arrows) 
and spontaneous depolarisations, probably reflecting synaptic 
activity (black arrows). The bottom panel shows the response to 
the largest depolarising current injection on an expanded scale. A 
negative holding current was applied to hyperpolarise the neuron, 
the injection begins at 50 ms. (b). An equivalent recording from a 
GFP- neuron.  
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TABLES.  
 
Table 1. Comparison of voltage-dependent Na+ and K+ currents in GFP+ and GFP- (control) neurons in 
voltage-clamp. 
 
GFP positive 
(n = 8) 
GFP negative 
(n = 6) 
Em (mV) -38 ± 1 -32 ± 3 
INa at -30 mV (pA) -271 ± 88 -385 ± 144 
IK at -30 mV (pA) 70 ± 20 33 ± 9 
IK at 0 mV (pA) 806 ± 235 807 ± 257 
Table 1. Comparison of voltage-dependent Na+ and K+ currents in GFP+ and GFP- neurons in voltage-clamp. Current amplitudes 
were measured at the voltages indicated. For the measurements made at -30 mV, records were made using leak subtracted records. 
Membrane potential (Em) measurements are also shown, measured by linear interpolation of I-V curves at I = 0. There were no 
significant differences between the means for GFP+ and GFP- neurons (Student’s t test). Values are mean ± SEM, given to the nearest 
whole number.  
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